UBS Group AG Becomes Substantial Holder in Artrya Limited with 6.93% Voting Power

Manish Choudhary

09 November 2026 05:52 PM AEDT

UBS Group AG Becomes Substantial Holder in Artrya Limited with 6.93% Voting Power

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Artrya Limited (ASX:AYA) has disclosed that UBS Group AG and its related bodies corporate became a substantial holder in the company on 5 November 2026, acquiring a relevant interest in 11,345,823 ordinary shares, representing 6.93% voting power.

Key Points

UBS Group AG and its related bodies corporate became a substantial holder in Artrya Limited on 5 November 2026
The combined relevant interest covers 11,345,823 ordinary shares, carrying 11,345,823 votes and 6.93% voting power
Four UBS entities hold relevant interests: UBS AG Australia Branch, UBS AG London Branch, UBS Asset Management (Australia) Ltd, and UBS Securities Australia Ltd
The notice was signed on 9 November 2026 by Ruby Ko, authorised signatory, on behalf of UBS Group AG

Breakdown of Relevant Interests Across UBS Entities

The 11,345,823 ordinary shares are held across multiple UBS entities. UBS AG Australia Branch holds a relevant interest in 4,264,300 ordinary shares as a prime broker that has exercised its borrowing right pursuant to a Prime Broking Agreement. UBS Securities Australia Ltd holds a relevant interest in 3,667,730 ordinary shares through power to control disposal pursuant to stock borrowing and lending activities. UBS Asset Management (Australia) Ltd holds a relevant interest in 3,232,479 ordinary shares as a fund manager with power to exercise control over voting shares. UBS AG London Branch holds a relevant interest in a combined 181,314 ordinary shares through prime broking and stock lending arrangements.

Registered Holders of the Relevant Securities

According to the filing, the securities subject to the relevant interests are registered across several custodian entities. UBS Nominees Pty Ltd is registered as holder of the 4,264,300 ordinary shares attributed to UBS AG Australia Branch. Warbont Nominees Pty Ltd holds the 3,667,730 ordinary shares attributed to UBS Securities Australia Ltd. Various custodians hold the 3,232,479 ordinary shares attributed to UBS Asset Management (Australia) Ltd, and the 4,202 ordinary shares attributed to UBS AG London Branch. Citicorp Nominees Pty Ltd holds 177,112 ordinary shares attributed to UBS AG London Branch. All named entities are identified in the filing as related bodies corporate of UBS Group AG.

Nature of Agreements Underpinning the Relevant Interests

The filing discloses that the relevant interests arise under Prime Brokerage Agreements and Securities Lending Agreements. Under the Prime Brokerage Agreements, UBS AG holds voting rights over shares where it has exercised its borrowing right, though in certain circumstances it may seek to arrange for voting rights to be exercised in accordance with the instructions of the transferor client. Under the Securities Lending Agreements, all right and title in the securities passes to the transferee, conferring voting rights on that transferee. The filing states both borrowers and lenders retain early return and early recall rights respectively, subject to the terms of the relevant loans.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.